Similar to the events of the fungal meningitis outbreak of September 2012, a compounding pharmacy has recalled a number of drugs due to mold contamination. Michael Omidi examines the recall and the reasons behind it.
A compounding pharmacy in New Jersey, Med Prep Consulting Inc., recently announced a recall of their products including drugs utilized in surgeries and labor as well as pain relievers and antibiotics, leading the United States Food and Drug Administration (FDA) to issue warnings to medical and healthcare professionals.
The recall is not a result of illnesses being reported as in the case of the fungal meningitis outbreak caused by products from the New England Compounding Center, but there is concern from the FDA that the mold contamination found in the products could result in illness for patients. The FDA is currently working with health officials in the states of New Jersey and Connecticut to isolate any potential contamination.
The products that are being recalled are used for those that are hospitalized inpatient or outpatient and are only provided by trained healthcare professionals at facilities, practices, or clinics. None of the products are directly released to patients for at-home use or self-administration.
All of the facilities that have received the products believed to be contaminated have been notified and a full list of the products that have been recalled can be found in a press release from Med Prep on the FDA website.
You actually make it seem so easy with your presentation but I find this matter to be really something that I think I would never understand. It seems too complex and very broad for me. I am looking forward for your next post; I’ll try to get the hang of it!Wellness Pharmacy
ReplyDelete